At the end of 2019, the cause of pneumonia outbreaks in Wuhan, China, was identified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In February 2020, the World Health Organization named the disease cause by SARS-CoV-2 as coronavirus disease 2019 (COVID-19). In response to the pandemic, the Korean Cancer Association formed the COVID-19 task force to develop practice guidelines. This special article introduces the clinical practice guidelines for cancer patients which will help oncologists best manage cancer patients during the COVID-19 pandemic.
Bibliographical noteFunding Information:
We would like to thank all the board members from the Korean Cancer Association and the Office of Public Relations and Collaboration at the National Cancer Center, South Korea, for supporting the development of these COVID-19 clinical practice guidelines for cancer care.
Copyright © 2021 by the Korean Cancer Association
All Science Journal Classification (ASJC) codes
- Cancer Research